Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trial
- Nan Niu
- Jinqi Xue
- Guanglei Chen
- Fang Qiu
- Qianshi Xu
- Xinyu Zheng
- Chao Liu
- Yafei Zhao
- Xi Gu
- Yi Zhao
- Hong Xu
- Hao Zhang
- Guijin He
- Ke Li
- Pengfei Li
- Xiaoying Chen
- Yong Li
- Shuo Wang
- Demiao Zhu
- Tong Liu
- Fei Xing
- Yongqing Xu
- Ye Han
- Meiyue Tang
- Mingxin Liu
- Gege Jiao
- Xiaofan Jiang
- Tony Yuen
- Zheng Pang
- Caigang Liu
2025-07-01